CA2135645A1 - Expression amelioree de genes humains de resistance a plusieurs medicaments et selection amelioree des cellules transduites avec lesdits genes - Google Patents

Expression amelioree de genes humains de resistance a plusieurs medicaments et selection amelioree des cellules transduites avec lesdits genes

Info

Publication number
CA2135645A1
CA2135645A1 CA002135645A CA2135645A CA2135645A1 CA 2135645 A1 CA2135645 A1 CA 2135645A1 CA 002135645 A CA002135645 A CA 002135645A CA 2135645 A CA2135645 A CA 2135645A CA 2135645 A1 CA2135645 A1 CA 2135645A1
Authority
CA
Canada
Prior art keywords
dna
cells
changed
sequence
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002135645A
Other languages
English (en)
Inventor
Kevin T. Mcdonagh
Arthur W. Nienhuis
Paul Tolstoshev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Therapy Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2135645A1 publication Critical patent/CA2135645A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002135645A 1992-05-22 1993-05-14 Expression amelioree de genes humains de resistance a plusieurs medicaments et selection amelioree des cellules transduites avec lesdits genes Abandoned CA2135645A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88771292A 1992-05-22 1992-05-22
US887,712 1992-05-22

Publications (1)

Publication Number Publication Date
CA2135645A1 true CA2135645A1 (fr) 1993-12-09

Family

ID=25391705

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002135645A Abandoned CA2135645A1 (fr) 1992-05-22 1993-05-14 Expression amelioree de genes humains de resistance a plusieurs medicaments et selection amelioree des cellules transduites avec lesdits genes

Country Status (5)

Country Link
US (1) US5837536A (fr)
EP (1) EP0646171A4 (fr)
JP (1) JPH09503641A (fr)
CA (1) CA2135645A1 (fr)
WO (1) WO1993024613A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009120A1 (fr) * 1992-10-16 1994-04-28 The Trustees Of Columbia University In The City Of New York Transfert a mediation retrovirale du gene humain de resistance a de multiples medicaments
US5866699A (en) * 1994-07-18 1999-02-02 Hybridon, Inc. Oligonucleotides with anti-MDR-1 gene activity
AU4214799A (en) 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
US7622557B2 (en) 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
CA2384981A1 (fr) * 1999-09-28 2001-04-05 Gentest Corporation Glycoproteines p et leurs utilisations
AU7835600A (en) * 1999-09-28 2001-04-30 Gentest Corporation P-glycoproteins from macaca fascicularis and uses thereof
AU3922802A (en) * 2000-10-02 2002-05-27 Keck Graduate Inst Methods for identifying nucleotides at defined positions in target nucleic acidsusing fluorescence polarization
US7445897B2 (en) * 2004-01-26 2008-11-04 University Of Washington Sequence variants of multi-drug resistance genes, MDR1 and MRP1, and methods for assessment of drug penetration and disposition
US20070198043A1 (en) * 2006-02-22 2007-08-23 Cox Daniel L Bone marrow aspiration device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174810B1 (fr) * 1984-09-10 1993-07-21 HSC Research Development Corporation Lignes de cellules de mammifères résistantes à plusieurs médicaments et isolement de l'ADN de la glycoprotéine déterminante
US5206352A (en) * 1986-03-28 1993-04-27 Board Of Trustees Of The University Of Illinois Compositions for clones containing DNA sequences associated with multidrug resistance in human cells
US5198344A (en) * 1986-07-15 1993-03-30 Massachusetts Institute Of Technology DNA sequence that encodes the multidrug resistance gene
US5166059A (en) * 1987-06-16 1992-11-24 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy using gene fusions for genetic or acquired disorders
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
JPH02100680A (ja) * 1988-10-05 1990-04-12 Suntory Ltd ヒト正常細胞由来ｍｄｒ関連遺伝子
EP0451157A4 (en) * 1988-10-21 1992-01-02 Us Health Transgenic animals for testing multidrug resistance
US5175099A (en) * 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
WO1991000361A1 (fr) * 1989-06-23 1991-01-10 The United States Of America, Represented By The Secretary, United States Department Of Commerce Procede efficace pour une expression identifiable de genes non selectionnables
US5464753A (en) * 1991-03-08 1995-11-07 Univ Illinois Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
WO1994009120A1 (fr) * 1992-10-16 1994-04-28 The Trustees Of Columbia University In The City Of New York Transfert a mediation retrovirale du gene humain de resistance a de multiples medicaments

Also Published As

Publication number Publication date
EP0646171A1 (fr) 1995-04-05
EP0646171A4 (fr) 1998-01-07
US5837536A (en) 1998-11-17
WO1993024613A1 (fr) 1993-12-09
JPH09503641A (ja) 1997-04-15

Similar Documents

Publication Publication Date Title
EP0871754B1 (fr) Procede de production de lignees de cellules d'encapsidation retrovirales generant un surnageant retroviral a efficacite de transduction elevee
Bunnell et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.
Mosca et al. Mesenchymal stem cells as vehicles for gene delivery.
EP0572401B1 (fr) Particules virales agissant sur une gamme d'hotes modifiee
Bierhuizen et al. Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells
CA2258007A1 (fr) Procedes et compositions permettant de transformer des cellules
US6995009B1 (en) Packaging cell
Havenga et al. Retroviral stem cell gene therapy
Uckert et al. Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype
NL9101680A (nl) Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
AU1333797A (en) Method for obtaining retroviral vector supernatant having high transduction efficiency
CA2135645A1 (fr) Expression amelioree de genes humains de resistance a plusieurs medicaments et selection amelioree des cellules transduites avec lesdits genes
US6368862B1 (en) Polymerase I promoter plasmid and vector constructs
JPH11511651A (ja) 遺伝子治療に特に適した改良型レトロウイルスベクター
EP0716710B1 (fr) Procedes de suppression de la reponse immunitaire par therapie genique
WO1999047659A1 (fr) Utilisation de particules vecteurs resistant au serum humain et des lignees cellulaires pour la therapie genique humaine
Kume et al. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors
EP4286401A1 (fr) Utilisation d'une protéine artificielle ou d'un acide nucléique codant la protéine artificielle pour fournir un complexe de ribonucléoprotéines fonctionnel
US8309071B2 (en) Foamy viral envelope genes
Lee et al. [42] Retroviral transfer of human MDR1 gene into human T lymphocytes
EP2138584B1 (fr) Gènes à enveloppe virale mousseuse
AU663470C (en) Viral particles having altered host range
Bierhuizen et al. Efficient detection and selection of immature rhesus monkey and human CD34+ hematopoietic cells expressing the enhanced green fluorescent protein (EGFP)
EP1081227A1 (fr) Procedes et moyens pour l'apport retroviral de genes
US20020164800A1 (en) Retroviral vector

Legal Events

Date Code Title Description
FZDE Discontinued